{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:09:55Z","timestamp":1779376195307,"version":"3.53.1"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec id=\"ab-eoi260016-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>\n                      Aconitase 2 (\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      ) gene variants are one of the most frequent causes of dominant optic atrophy (DOA). However, the associated phenotypes and genotypes still lack proper characterization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260016-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To characterize the clinical and genetic spectrum of\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      -related DOA and evaluate genotype-phenotype correlations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260016-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      This was a retrospective case series to describe the ophthalmological examination of novel DOA cases with a heterozygous\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      variant. Data were collected from 13 reference centers in ophthalmology from France and Great Britain between January 2021 and September 2025. Included participants were those patients with OA and confirmed heterozygous or compound heterozygous\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260016-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>\n                      DOA cases with a heterozygous\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      variant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260016-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      Positive molecular diagnosis for\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      variants by next-generation sequencing, clinical examination including age at diagnosis, sex, best-corrected visual acuity (BCVA), retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) thickness, visual field mean deviation (MD), and fundus examination.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260016-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data for 55 patients (median [IQR] age at diagnosis for 45 patients, 24 [8-51] years; 33 male [67%]) from 37 families with\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      variants were compiled. Analyses were conducted on 49 patients who were strictly heterozygous or compound heterozygous with the c.220C&amp;amp;gt;G benign variant. Clinical data disclosed a high variability of severity, from pauci-symptomatic up to legal blindness. Median BCVA was 0.46 logMAR (Snellen equivalent, 20\/63; IQR 0.00-0.89; n\u2009=\u200945). Four patients exhibited retinal abnormalities: 3 displayed a foveopathy, and 1 had retinitis pigmentosa. There were 12 previously unreported variants (to the authors\u2019 knowledge), including the deletion of\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      exon 9. No correlation between BCVA and sex, age at diagnosis (Spearman \u03c1\u2009=\u2009\u22120.19; 95% CI, \u22120.45 to 0.07), or variant type (Kruskal-Wallis test\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.33) was found, but there was a correlation between BCVA and RNFL (Spearman \u03c1\u2009=\u2009\u22120.74; 95% CI, \u22120.85 to \u22120.54), GCL (Spearman \u03c1\u2009=\u2009\u22120.60; 95% CI, \u22120.79 to \u22120.30), and MD (Spearman \u03c1\u2009=\u2009\u22120.65; 95% CI, \u22120.89 to \u22120.31). RNFL correlated with GCL (Spearman \u03c1\u2009=\u20090.69; 95% CI, 0.42-0.87) and MD (Spearman \u03c1\u2009=\u20090.57; 95% CI, 0.14-0.85); age at diagnosis correlated with GCL (Spearman \u03c1\u2009=\u2009\u22120.37; 95% CI, \u22120.63 to \u22120.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260016-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>\n                      Results of this case series reveal the high clinical heterogeneity among patients with\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      -related DOA and demonstrated that some of these patients can also exhibit retinal abnormalities. In addition, there was a deletion of an entire\n                      <jats:italic toggle=\"yes\">ACO2<\/jats:italic>\n                      exon, emphasizing the potential importance of searching for large genomic rearrangements in patients without a molecular diagnosis. These findings support further studies to explain clinical variability, as no genotype-phenotype correlation was encountered.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.0634","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T15:00:35Z","timestamp":1775746835000},"page":"452","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Genetic Spectrum of\n                    <i>ACO2<\/i>\n                    -Linked Dominant Optic Atrophy"],"prefix":"10.1001","volume":"144","author":[{"given":"Cl\u00e9is","family":"Beaulieu","sequence":"first","affiliation":[{"name":"University of Angers, MitoLab Team, MitoVasc Unit, UMR CNRS 6015, Inserm U1083, SFR ICAT, University Hospital of Angers, Angers, France"},{"name":"Association Ouvrir Les Yeux, Lens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymane","family":"Bouzidi","sequence":"additional","affiliation":[{"name":"University of Angers, MitoLab Team, MitoVasc Unit, UMR CNRS 6015, Inserm U1083, SFR ICAT, University Hospital of Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Desquiret-Dumas","sequence":"additional","affiliation":[{"name":"University of Angers, MitoLab Team, MitoVasc Unit, UMR CNRS 6015, Inserm U1083, SFR ICAT, University Hospital of Angers, Angers, France"},{"name":"Department of Biochemistry and Molecular Biology, University Hospital of Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Dieu","sequence":"additional","affiliation":[{"name":"University of Angers, MitoLab Team, MitoVasc Unit, UMR CNRS 6015, Inserm U1083, SFR ICAT, University Hospital of Angers, Angers, France"},{"name":"Department of Biochemistry and Molecular Biology, University Hospital of Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Makam","sequence":"additional","affiliation":[{"name":"John van Geest Centre for Brain Repair and MRC Mitochondrial Biology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"},{"name":"Cambridge Eye Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom"},{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neringa","family":"Jurkute","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"Institute of Ophthalmology, University College London, London, United Kingdom"},{"name":"Department of Neuro-ophthalmology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vignal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hospital Fondation Adolphe de Rothschild, Paris, France"},{"name":"Quinze-Vingts National Ophthalmology Hospital, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Philibert","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hospital Fondation Adolphe de Rothschild, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Odent","sequence":"additional","affiliation":[{"name":"Clinical Genetics, CLAD-Ouest Reference Center for Rare Diseases, ERN-ITHACA, FHU GenOMedS, University Hospital of Rennes, Rennes, France"},{"name":"University of Rennes, CNRS, INSERM, IGDR (Institut de G\u00e9n\u00e9tique et D\u00e9veloppement de Rennes) - UMR 6290, ERL U1305, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Zanlonghi","sequence":"additional","affiliation":[{"name":"Competence Centers for Rare Diseases, Department of Ophthalmology, University Hospital of Rennes Pontchaillou, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Latypov","sequence":"additional","affiliation":[{"name":"Institute for Neurosciences of Montpellier, University of Montpellier, INSERM, Montpellier, France"},{"name":"National Reference Center for Inherited Sensory Diseases, University of Montpellier, CHU, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloi","family":"Debourdeau","sequence":"additional","affiliation":[{"name":"Institute for Neurosciences of Montpellier, University of Montpellier, INSERM, Montpellier, France"},{"name":"National Reference Center for Inherited Sensory Diseases, University of Montpellier, CHU, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Bocquet","sequence":"additional","affiliation":[{"name":"Institute for Neurosciences of Montpellier, University of Montpellier, INSERM, Montpellier, France"},{"name":"National Reference Center for Inherited Sensory Diseases, University of Montpellier, CHU, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raihane","family":"Yahia","sequence":"additional","affiliation":[{"name":"Institute for Neurosciences of Montpellier, University of Montpellier, INSERM, Montpellier, France"},{"name":"National Reference Center for Inherited Sensory Diseases, University of Montpellier, CHU, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Pons","sequence":"additional","affiliation":[{"name":"Deparment of Genetics, Hospital of Valence, Valence, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric Pollet","family":"Villard","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hospital of Valence, Valence, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Jeanjean","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital of N\u00eemes, France; ARAMAV Low Vision Institute, N\u00eemes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Verrecchia","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Neuro-Ophthalmology Unit, Hopital Neurologique et Neurochirurgical P Wertheimer, Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Froment","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Neuro-Ophthalmology Unit, Hopital Neurologique et Neurochirurgical P Wertheimer, Bron, France"},{"name":"Claude Bernard Lyon 1 University, CNRS, INSERM, Center for Research in Neurosciences of Lyon, CRNL U1028 UMR5292, IMPACT, Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Engel","sequence":"additional","affiliation":[{"name":"University of Franche-Comt\u00e9, Center for Human Genetics, University Hospital of Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Poirsier","sequence":"additional","affiliation":[{"name":"Functional Unit of Clinical Genetics, University Hospital of Reims, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Arndt","sequence":"additional","affiliation":[{"name":"University of Reims Champagne Ardennes, Reims, France; Department of Ophthalmology, Robert Debre University Hospital, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Dollfus","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Genetics, UMR_S INSERM U1112, Alsace Medical Genetics Institute (IGMA), University of Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gohier","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital of Angers, Angers. France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majida","family":"Charif","sequence":"additional","affiliation":[{"name":"Genetics and Immuno-Cell Therapy Team, Mohammed First University, Oujda, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ferr\u00e9","sequence":"additional","affiliation":[{"name":"University of Angers, MitoLab Team, MitoVasc Unit, UMR CNRS 6015, Inserm U1083, SFR ICAT, University Hospital of Angers, Angers, France"},{"name":"Department of Biochemistry and Molecular Biology, University Hospital of Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Prunier-Mirebeau","sequence":"additional","affiliation":[{"name":"University of Angers, MitoLab Team, MitoVasc Unit, UMR CNRS 6015, Inserm U1083, SFR ICAT, University Hospital of Angers, Angers, France"},{"name":"Department of Biochemistry and Molecular Biology, University Hospital of Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meunier","sequence":"additional","affiliation":[{"name":"Institute for Neurosciences of Montpellier, University of Montpellier, INSERM, Montpellier, France"},{"name":"National Reference Center for Inherited Sensory Diseases, University of Montpellier, CHU, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yu-Wai-Man","sequence":"additional","affiliation":[{"name":"John van Geest Centre for Brain Repair and MRC Mitochondrial Biology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"},{"name":"Cambridge Eye Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom"},{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"Institute of Ophthalmology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Amati-Bonneau","sequence":"additional","affiliation":[{"name":"University of Angers, MitoLab Team, MitoVasc Unit, UMR CNRS 6015, Inserm U1083, SFR ICAT, University Hospital of Angers, Angers, France"},{"name":"Department of Biochemistry and Molecular Biology, University Hospital of Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lenaers","sequence":"additional","affiliation":[{"name":"University of Angers, MitoLab Team, MitoVasc Unit, UMR CNRS 6015, Inserm U1083, SFR ICAT, University Hospital of Angers, Angers, France"},{"name":"Department of Neurology, University Hospital of Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily","family":"Smirnov","sequence":"additional","affiliation":[{"name":"Service d\u2019Exploration de la Vision et de Neuro-Ophtalmologie, Roger Salengro Hospital, University Hospital of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"eoi260016r1","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/sj.eye.6701570","article-title":"Molecular genetic basis of primary inherited optic neuropathies.","volume":"18","author":"Votruba","year":"2004","journal-title":"Eye (Lond)"},{"issue":"5","key":"eoi260016r2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbabio.2009.02.024","article-title":"Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders.","volume":"1787","author":"Carelli","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"eoi260016r3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1474-4422(22)00174-0","article-title":"Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management.","volume":"22","author":"Newman","year":"2023","journal-title":"Lancet Neurol"},{"issue":"2","key":"eoi260016r4","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab063","article-title":"Dominant ACO2 mutations are a frequent cause of isolated optic atrophy.","volume":"3","author":"Charif","year":"2021","journal-title":"Brain Commun"},{"issue":"2","key":"eoi260016r5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/brain\/awac395","article-title":"The top 10 most frequently involved genes in hereditary optic neuropathies in 2186 probands.","volume":"146","author":"Rocatcher","year":"2023","journal-title":"Brain"},{"issue":"9","key":"eoi260016r6","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/brain\/awad080","article-title":"The Italian reappraisal of the most frequent genetic defects in hereditary optic neuropathies and the global top 10.","volume":"146","author":"Fiorini","year":"2023","journal-title":"Brain"},{"issue":"2","key":"eoi260016r7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"issue":"13","key":"eoi260016r8","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/hmg\/7.13.2021","article-title":"Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein.","volume":"7","author":"Strom","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"5","key":"eoi260016r9","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/brain\/awae324","article-title":"Clinical and genetic landscape of optic atrophy in 826 families: insights from 50 nuclear genes.","volume":"148","author":"Zheng","year":"2025","journal-title":"Brain"},{"issue":"4","key":"eoi260016r10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ajhg.2017.09.007","article-title":"FDXR mutations cause sensorial neuropathies and expand the spectrum of mitochondrial Fe-S-synthesis diseases.","volume":"101","author":"Paul","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"24","key":"eoi260016r11","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1093\/hmg\/ddx377","article-title":"Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy.","volume":"26","author":"Peng","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"18","key":"eoi260016r12","doi-asserted-by":"publisher","first-page":"9950","DOI":"10.3390\/ijms25189950","article-title":"Mitochondrial aconitase and its contribution to the pathogenesis of neurodegenerative diseases.","volume":"25","author":"Padalko","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"eoi260016r13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ajhg.2012.01.009","article-title":"Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2.","volume":"90","author":"Spiegel","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"2","key":"eoi260016r14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/jimd.12022","article-title":"Clinical, radiological, and genetic characteristics of 16 patients with ACO2 gene defects: delineation of an emerging neurometabolic syndrome.","volume":"42","author":"Sharkia","year":"2019","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"eoi260016r15","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000223","article-title":"ACO2 homozygous missense mutation associated with complicated hereditary spastic paraplegia.","volume":"4","author":"Bouwkamp","year":"2018","journal-title":"Neurol Genet"},{"issue":"2","key":"eoi260016r16","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000225","article-title":"ACO2 mutations: a novel phenotype associating severe optic atrophy and spastic paraplegia.","volume":"4","author":"Marelli","year":"2018","journal-title":"Neurol Genet"},{"issue":"1","key":"eoi260016r17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41439-021-00136-y","article-title":"Complex hereditary spastic paraplegia associated with episodic visual loss caused by ACO2 variants.","volume":"8","author":"Tozawa","year":"2021","journal-title":"Hum Genome Var"},{"issue":"12","key":"eoi260016r18","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/jmedgenet-2014-102532","article-title":"Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encephalopathy and cerebellar atrophy.","volume":"51","author":"Metodiev","year":"2014","journal-title":"J Med Genet"},{"key":"eoi260016r19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.602979","article-title":"Use of next-generation sequencing for the molecular diagnosis of 1102 patients with a autosomal optic neuropathy.","volume":"12","author":"Charif","year":"2021","journal-title":"Front Neurol"},{"issue":"1","key":"eoi260016r20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature.","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"43","key":"eoi260016r22","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse.","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"issue":"1","key":"eoi260016r23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package.","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R J"},{"key":"eoi260016r24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1172-7-46","article-title":"Dominant optic atrophy.","volume":"7","author":"Lenaers","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"eoi260016r25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.mito.2018.07.006","article-title":"Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.","volume":"46","author":"Ham","year":"2019","journal-title":"Mitochondrion"},{"issue":"D1","key":"eoi260016r26","doi-asserted-by":"publisher","first-page":"D948","DOI":"10.1093\/nar\/gkae1071","article-title":"Ensembl 2025.","volume":"53","author":"Dyer","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"eoi260016r27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41597-021-00984-x","article-title":"ACO2 clinicobiological dataset with extensive phenotype ontology annotation.","volume":"8","author":"Guehlouz","year":"2021","journal-title":"Sci Data"},{"issue":"1","key":"eoi260016r28","doi-asserted-by":"publisher","first-page":"22956","DOI":"10.1038\/s41598-024-74364-x","article-title":"Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy.","volume":"14","author":"de Muijnck","year":"2024","journal-title":"Sci Rep"},{"key":"eoi260016r29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1609033","article-title":"Technological advances in the diagnosis and management of inherited optic neuropathies.","volume":"16","author":"Britton","year":"2025","journal-title":"Front Neurol"},{"key":"eoi260016r30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ajo.2024.01.011","article-title":"AFG3L2 and ACO2-linked dominant optic atrophy: genotype-phenotype characterization compared to OPA1 patients.","volume":"262","author":"Amore","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"eoi260016r31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nbd.2015.08.015","article-title":"OPA1-related disorders: diversity of clinical expression, modes of inheritance and pathophysiology.","volume":"90","author":"Chao de la Barca","year":"2016","journal-title":"Neurobiol Dis"},{"issue":"8","key":"eoi260016r32","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.ophtha.2009.12.038","article-title":"The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.","volume":"117","author":"Yu-Wai-Man","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi260016r33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/acn3.51074","article-title":"Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in ACO2.","volume":"7","author":"Blackburn","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"eoi260016r34","doi-asserted-by":"publisher","first-page":"18703","DOI":"10.1038\/s41598-021-98150-1","article-title":"Characterization of SSBP1-related optic atrophy and foveopathy.","volume":"11","author":"Meunier","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"eoi260016r35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1172\/JCI128513","article-title":"Dominant mutations in mtDNA maintenance gene SSBP1 cause optic atrophy and foveopathy.","volume":"130","author":"Piro-M\u00e9gy","year":"2020","journal-title":"J Clin Invest"},{"issue":"2","key":"eoi260016r36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0888-7543(95)80058-T","article-title":"Chromosomal localization of mitochondrial transcription factor A (TCF6), single-stranded DNA-binding protein (SSBP), and endonuclease G (ENDOG), 3 human housekeeping genes involved in mitochondrial biogenesis.","volume":"25","author":"Tiranti","year":"1995","journal-title":"Genomics"},{"issue":"3","key":"eoi260016r37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/ana.25550","article-title":"SSBP1 mutations in dominant optic atrophy with variable retinal degeneration.","volume":"86","author":"Jurkute","year":"2019","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"eoi260016r38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multisystem neurological disease is common in patients with OPA1 mutations.","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"issue":"1","key":"eoi260016r39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13023-019-1187-1","article-title":"OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database.","volume":"14","author":"Le Roux","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"Pt 7","key":"eoi260016r40","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws340","article-title":"Sensorineural hearing loss in OPA1-linked disorders.","volume":"136","author":"Leruez","year":"2013","journal-title":"Brain"},{"issue":"1-2","key":"eoi260016r41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0378-1119(98)00188-7","article-title":"Characterization of the human mitochondrial aconitase gene (ACO2).","volume":"213","author":"Mirel","year":"1998","journal-title":"Gene"},{"issue":"5710","key":"eoi260016r42","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1126\/science.1106391","article-title":"Aconitase couples metabolic regulation to mitochondrial DNA maintenance.","volume":"307","author":"Chen","year":"2005","journal-title":"Science"},{"issue":"1","key":"eoi260016r43","doi-asserted-by":"publisher","first-page":"16736","DOI":"10.1038\/s41598-020-73557-4","article-title":"Haploinsufficiency due to a novel ACO2 deletion causes mitochondrial dysfunction in fibroblasts from a patient with dominant optic nerve atrophy.","volume":"10","author":"Neumann","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"eoi260016r44","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/cells10071593","article-title":"The influence of mitochondrial dynamics and function on retinal ganglion cell susceptibility in optic nerve disease.","volume":"10","author":"Muench","year":"2021","journal-title":"Cells"},{"issue":"8","key":"eoi260016r45","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1136\/jmg.39.8.e47","article-title":"Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease.","volume":"39","author":"Marchbank","year":"2002","journal-title":"J Med Genet"},{"key":"eoi260016r46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1471-2350-12-49","article-title":"Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy.","volume":"12","author":"Almind","year":"2011","journal-title":"BMC Med Genet"},{"issue":"1","key":"eoi260016r47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12920-024-01850-6","article-title":"Genetic underpinnings explored: OPA1 deletion and complex phenotypes on chromosome 3q29.","volume":"17","author":"Wang","year":"2024","journal-title":"BMC Med Genomics"},{"issue":"5","key":"eoi260016r48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10384-017-0522-0","article-title":"Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.","volume":"61","author":"Hayashi","year":"2017","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"eoi260016r49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/jmg.2008.062570","article-title":"Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy.","volume":"46","author":"Fuhrmann","year":"2009","journal-title":"J Med Genet"},{"issue":"8","key":"eoi260016r50","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1002\/ajmg.a.61634","article-title":"Recessive ACO2 variants as a cause of isolated ophthalmologic phenotypes.","volume":"182","author":"Gibson","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"11","key":"eoi260016r51","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/s41436-021-01250-6","article-title":"High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 families.","volume":"23","author":"Benkirane","year":"2021","journal-title":"Genet Med"},{"issue":"1","key":"eoi260016r52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12967-024-05334-0","article-title":"Genetic susceptibility to optic neuropathy in patients with alcohol use disorder.","volume":"22","author":"Delibes","year":"2024","journal-title":"J Transl Med"},{"issue":"3","key":"eoi260016r53","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ajo.2014.05.034","article-title":"Early macular retinal ganglion cell loss in dominant optic atrophy: genotype-phenotype correlation.","volume":"158","author":"Barboni","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"eoi260016r54","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1111\/jcmm.13149","article-title":"Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy.","volume":"21","author":"Kane","year":"2017","journal-title":"J Cell Mol Med"},{"issue":"7","key":"eoi260016r55","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/cimb47070504","article-title":"Mapping disorders with neurological features through mitochondrial impairment pathways: insights from genetic evidence.","volume":"47","author":"Makridou","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"eoi260016r56","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.115073","article-title":"Disease registries and rare disorders: The virtuous example of mitochondrial medicine.","volume":"384","author":"Orsucci","year":"2025","journal-title":"Exp Neurol"},{"issue":"12","key":"eoi260016r57","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/genes15121559","article-title":"Insights on the genetic and phenotypic complexities of optic neuropathies.","volume":"15","author":"D\u2019Esposito","year":"2024","journal-title":"Genes (Basel)"},{"issue":"Pt 9","key":"eoi260016r58","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/brain\/awp158","article-title":"Gene-environment interactions in Leber hereditary optic neuropathy.","volume":"132","author":"Kirkman","year":"2009","journal-title":"Brain"},{"key":"eoi260016r59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mito.2017.07.004","article-title":"Incomplete penetrance in mitochondrial optic neuropathies.","volume":"36","author":"Caporali","year":"2017","journal-title":"Mitochondrion"},{"issue":"3","key":"eoi260016r60","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3390\/biomedicines12030584","article-title":"The optic nerve at stake: update on environmental factors modulating expression of Leber hereditary optic neuropathy.","volume":"12","author":"Layrolle","year":"2024","journal-title":"Biomedicines"},{"issue":"11","key":"eoi260016r61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225656","article-title":"An evaluation of genetic causes and environmental risks for bilateral optic atrophy.","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"eoi260016r21","unstructured":"World Health Organization (WHO). International Classification of Diseases, Eleventh Revision (ICD-11) morbidity and mortality statistics. Accessed June 16, 2025. https:\/\/icd.who.int\/browse11"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2847243\/jamaophthalmology_beaulieu_2026_oi_260016_1778698661.75266.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:00:49Z","timestamp":1779375649000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2847243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.0634","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}